As of 30 Sep 2025, 30 institutional investors reported holding 4,021,743 shares of Tiziana Life Sciences Ltd - COMMON SHARES (TLSA).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 258 | $385 | $1.49 | 1 | |
| 2025 Q3 | 4,021,743 | $8,683,234 | +$546,892 | $2.16 | 30 |
| 2025 Q2 | 1,141,026 | $1,797,401 | -$72,991 | $1.58 | 29 |
| 2025 Q1 | 2,998,372 | $3,249,229 | +$2,269,465 | $1.08 | 32 |
| 2024 Q4 | 1,002,482 | $698,255 | -$957,264 | $0.70 | 33 |
| 2024 Q3 | 1,860,010 | $1,779,369 | +$894,808 | $0.96 | 29 |
| 2024 Q2 | 924,120 | $850,463 | +$107,206 | $0.92 | 25 |
| 2024 Q1 | 745,805 | $329,948 | +$1,199 | $0.45 | 17 |
| 2023 Q4 | 788,263 | $439,827 | -$699 | $0.56 | 19 |
| 2023 Q3 | 782,198 | $517,885 | -$62,103 | $0.66 | 21 |
| 2023 Q2 | 869,851 | $596,842 | -$261,033 | $0.68 | 18 |
| 2023 Q1 | 1,075,723 | $1,150,306 | -$2,530,294 | $1.09 | 18 |
| 2022 Q4 | 5,277,287 | $3,162,294 | -$33,844 | $0.60 | 19 |
| 2022 Q3 | 5,136,954 | $3,999,000 | -$27,854 | $0.77 | 18 |
| 2022 Q2 | 5,325,700 | $3,967,000 | -$279,899 | $0.74 | 18 |
| 2022 Q1 | 5,651,189 | $5,938,000 | -$28,207 | $1.05 | 19 |
| 2021 Q4 | 5,814,911 | $5,633,000 | +$5,633,041 | $0.96 | 20 |